Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Learn Which Crypto Assets Are Considered Low Risk and how to compare safety factors. This intro helps you screen assets with prudent criteria.
27,883 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Pagaya Technologies just saw a notable insider move when its CEO purchased shares. This article examines what that co...
Looking for growth you can ride for years? This guide breaks down three powerhouse names—NVIDIA, Microsoft, and Alpha...
July can bring clear catalysts for Disney stock investors. This guide highlights three dates to watch, explains why t...
When a fund exits its Brookdale Senior Living stake, it raises questions about momentum and risk. This guide breaks d...
NVIDIA stock has dipped below $200 again, prompting questions about its upside. This article breaks down the catalyst...
A drone maker sparked a quick rally before giving up gains as contract news hit. This piece breaks down why aeroviron...
President Trump touts a plan for a government-backed insurance agency to cover Gulf shipping against political risk. ...
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
In early 2026, Tutor Perini faced a mix of growth opportunities and project-level headwinds. This article breaks down...
As the market eyes a 4.5% yield from the LQD ETF, investors should scrutinize BBB credit risk and rate sensitivity th...
A 70,000-seat return in a government-backed venue stirs more than cheers. This article breaks down the money side of ...